Neural Interface Device by Borui Kang Gains Medical Insurance Coverage Just 10 Days After Market Launch

On the 13th of this month, Neuracle's implantable brain-computer interface product was approved by the National Medical Products Administration for global首发上市; on the 23rd, the municipal medical insurance department included the product in the city's medical insurance medical consumables directory; on the 24th, the product completed the listing on the Sunshine Procurement Platform.

From Approval to Inclusion in the Medical Insurance Catalog in Just 10 Days: Shanghai’s “Medical Insurance Speed” Bridges Key Steps from “Lab” to “Bedside,” Accelerating Patient Access to Cutting-Edge Brain-Computer Interface Technology. Behind this, the city's medical insurance department has played a pivotal role in policy guidance and service support, establishing a full-cycle support system covering R&D, clinical trials, and market launch, empowering the entire chain to promote high-quality development of the biopharmaceuticals industry.

Achieve "Shanghai Speed"

The transformation and implementation of brain-computer interface products and technologies exemplify the "Shanghai speed" in translating innovative achievements into practical results.

During the product development phase, the municipal medical insurance department proactively connected with enterprises to identify relevant supporting policies in advance. From 2024 to present, it has continuously followed up on the research and development progress, technical features, and product approval matters of several key brain-computer interface enterprises in the city, clarifying these aspects ahead of time.Innovative HealthcareMedical Device Medicare Support Policies and Procedures, Providing Clear Policy Expectations for Enterprises.

During the clinical trial phase, the municipal medical insurance department focuses on clinical realities to ensure policy alignment for clinical applications. In November 2024, the first clinical trial implant surgery for a brain-computer interface product in Shanghai was successfully performed. The municipal medical insurance department closely monitored the progress of this clinical application, comprehensively reviewed key issues such as policy alignment in technical applications, and proactively provided policy guidance and service support, adhering to the work principle of “Where there is a clinical need, medical insurance services will follow.”

In August 2025, the municipal medical insurance department, in collaboration with the municipal health commission, added three brain-computer interface related medical service projects to establish a policy pathway for the standard implementation of cutting-edge medical technologies, addressing the critical step from technological breakthrough to clinical accessibility. Meanwhile, they are studying the inclusion of brain-computer interface medical services within the scope of medical insurance payments.

During the product launch phase, the municipal medical insurance department provides "one-stop" coaching services. Taking Neuracle's implantable brain-computer interface product as an example, after receiving approval from the National Medical Products Administration, the municipal medical insurance department promptly guided the company in completing the application for the classification and coding of medical insurance medical consumables, while simultaneously communicating with the National Healthcare Security Administration to expedite the approval process. After obtaining the catalog and code, the city utilized a green channel to quickly complete the official documentation process, incorporating this innovative product into the medical insurance medical consumables directory. The online listing process was also optimized to ensure the product entered clinical use efficiently and smoothly.

Fully Support "True Innovation"

Biopharmaceuticals are the core track of Shanghai's emerging pillar industry, and brain-computer interface, as a "black technology" in the frontier interdisciplinary field, is even more a touchstone to test the city's scientific and technological innovation strength and medical insurance service capability. The municipal medical insurance department fully plays the role of medical insurance in line with Shanghai's goal of building the "the most friendly city for global innovative drugs and devices", smoothes the whole chain of innovative achievements transformation, and injects medical insurance momentum into the high-quality development of the biopharmaceuticals industry with "Shanghai speed" and "Shanghai strength".

Not Limited to Brain-Computer Interfaces: Innovative Support Measures by City Medical Insurance Authorities Now Fully Extend to Cover the Entire Biomedical Industry, Continuously Optimizing Medical Insurance Services and Policy Supply. On one hand, focusing on cutting-edge fields such as brain-computer interfaces and AI + medicine, strongly supporting "genuine innovation" technology development and encouraging innovative medical services to be implemented as soon as possible; on the other hand, continuously optimizing the medical insurance access process for innovative medical devices, promoting the rapid transformation of innovative achievements, allowing Shanghai's scientific and technological innovations to better serve patients across China.

By reporter Chen Jialin